“Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators”. Iraqi Journal of Medical Sciences, vol. 23, no. 1, June 2025, https://doi.org/10.22578/qchesh02.